Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Roivant Sciences Ltd. (ROIV) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$2.00M |
|
$-265.89M |
|
$0.70M |
|
$1.30M |
|
$341.15M |
|
$-339.15M |
|
$48.78M |
|
$-290.37M |
|
$-311.96M |
|
$-313.70M |
|
$-313.70M |
|
$-313.70M |
|
$-333.56M |
|
$-339.15M |
|
$-338.46M |
|
696.86M |
|
696.86M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$4.66B |
|
$13.45M |
|
$565.48M |
|
$5.23B |
|
$151.96M |
|
-- |
|
$99.18M |
|
$251.14M |
|
$4.97B |
|
$4.97B |
|
$4.97B |
|
709.69M |
|
| Cash Flow Statement Financials | |
$-586.53M |
|
$-855.82M |
|
$203.01M |
|
$2.73B |
|
$1.49B |
|
$-1.24B |
|
$269.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
30.66 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
64.98% |
|
-16966.13% |
|
-16966.13% |
|
-- |
|
-14525.71% |
|
-13301.20% |
|
$-593.48M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-6.31% |
|
-6.31% |
|
-6.00% |
|
-6.31% |
|
$7.01 |
|
$-0.85 |
|
$-0.84 |
|